NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses
Montserrat García‐Closas(Institute of Cancer Research), Nathaniel Rothman(National Institutes of Health), Claudine Samanic(National Cancer Institute), Nilanjan Chatterjee(Johns Hopkins University), Manolis Kogevinas(Barcelona Institute for Global Health), Josep Lloreta(Universitat Pompeu Fabra), Núria Malats(Spanish National Cancer Research Centre), Reina García-Closas(Hospital Universitario de Canarias), Cònsol Serra(Universitat Pompeu Fabra), Debra T. Silverman(Department of Health and Human Services), Francisco X. Real(Universitat Pompeu Fabra), Mustafa Dosemeci(National Cancer Institute), Alfredo Carrato(Hospital General Universitario de Elche), Gemma Castaño‐Vinyals(Municipal Institute for Medical Research), David W. Hein(University of Louisville), Stephen J. Chanock(National Cancer Institute), Meredith Yeager(Frederick National Laboratory for Cancer Research), Montserrat Torà(Municipal Institute for Medical Research), F. FERNÁNDEZ(Municipal Institute for Medical Research), Sholom Wacholder(National Cancer Institute), Robert Welch(National Institutes of Health), Adonina Tardón(Universidad de Oviedo)
Cited by 631
Related Papers
LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants
|Bioinformatics|2015|2.2k
Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies
|JNCI Journal of the National Cancer Institute|2004|1.8k
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
|Nature Genetics|2007|1.5k
Replicating genotype–phenotype associations
|Nature|2007|1.4k